Involvement of ATP-dependent aminophospholipid translocation in maintaining phospholipid asymmetry in diamide-treated human erythrocytes.
Crosslinking of membrane skeletal proteins such as spectrin by oxidation of their SH-groups can be provoked by treatment of intact erythrocytes with diamide. Shortly after exposure of human erythrocytes to diamide and despite the transverse destabilization of the lipid bilayer that was observed in these cells (Franck, P.F.H., Op den Kamp, J.A.F., Roelofsen, B. and Van Deenen, L.L.M. (1986) Biochim. Biophys. Acta 857, 127-130), no abnormalities could be detected regarding the asymmetric distribution of the phospholipids when probed by either the prothrombinase assay or brief exposure of the cells to a modified phospholipase A2 with enhanced membrane penetrating capacity. This asymmetry appeared to undergo dramatic changes however, when the ATP content of the cytosol had decreased to less than 10% of its original level during prolonged incubation of the treated cells. These observations indicate that the initial maintenance of phospholipid asymmetry in diamide-treated erythrocytes can be solely ascribed to the action of the ATP-dependent aminophospholipid translocase. This view is supported by experiments involving radiolabeled phospholipids of which trace amounts had been inserted into the outer membrane leaflet of diamide-treated red cells and which still showed a preferential translocation of both aminophospholipids in favour of the inner monolayer, be it that the efficiency of the translocase was found to be impaired when compared to control cells.
Middlekoop
E
E
Centre for Biomembranes and Lipid Enzymology, University of Utrecht, The Netherlands.
Van der Hoek
E E
EE
Bevers
E M
EM
Comfurius
P
P
Slotboom
A J
AJ
Op den Kamp
J A
JA
Lubin
B H
BH
Zwaal
R F
RF
Roelofsen
B
B
D000255:Adenosine Triphosphate / Q000097:blood / Q000502:physiology*; D001391:Azo Compounds; D001780:Blood Coagulation Tests; D002352:Carrier Proteins / Q000097:blood*; D002463:Cell Membrane Permeability; D003958:Diamide; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008051:Lipid Bilayers / Q000502:physiology; D008560:Membrane Fluidity / Q000187:drug effects; D008565:Membrane Proteins; D010713:Phosphatidylcholines / Q000097:blood; D049294:Phospholipid Transfer Proteins; D010743:Phospholipids / Q000097:blood*
D001391:Azo Compounds; D002352:Carrier Proteins; D008051:Lipid Bilayers; D008565:Membrane Proteins; D010713:Phosphatidylcholines; D049294:Phospholipid Transfer Proteins; D010743:Phospholipids; D003958:Diamide; D000255:Adenosine Triphosphate